Letters
Covid-19: administration of end-of-life drugs
End-of-life planning: ideas are not new but a system is needed to implement them
BMJ 2020; 369 doi: https://doi.org/10.1136/bmj.m2401 (Published 17 June 2020) Cite this as: BMJ 2020;369:m2401- Richard Scheffer, retired consultant in palliative medicine
- Totnes TQ9 5HW, UK
- richard.scheffer{at}btinternet.com
In their editorial Bowers and colleagues highlight two important matters—long recognised by palliative care and primary care teams—in caring for the dying in their own home or a care home.1 Both matters need tackling to reduce delays in getting end-of-life drugs to suffering, dying people. Delays occur while prescriptions are written and processed and drugs delivered, especially after hours and at weekends. Any delay in getting this medication …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.